|1.||Su, Bin: 10 articles (05/2015 - 04/2007)|
|2.||Kulkarni, Shrinivas K: 7 articles (12/2007 - 05/2002)|
|3.||Dhir, Ashish: 6 articles (06/2010 - 12/2005)|
|4.||Kumar, Anil: 5 articles (12/2015 - 01/2007)|
|5.||Ahmed, Sagheer: 5 articles (08/2015 - 05/2006)|
|6.||Zhong, Bo: 5 articles (05/2015 - 08/2011)|
|7.||Thurnher, Dietmar: 5 articles (05/2009 - 11/2004)|
|8.||Candelario-Jalil, Eduardo: 5 articles (04/2008 - 10/2002)|
|9.||Bianchi, M: 5 articles (08/2007 - 07/2002)|
|10.||Wakabayashi, Keiji: 5 articles (03/2006 - 01/2002)|
01/01/1993 - "The antipyretic and analgesic efficacy of the 2 drugs was similar, although more patients had complete remission of pain after 4 days of treatment with nimesulide. "
10/01/1990 - "Treatment with nimesulide reduced both the pain and the tumefaction due to the inflammatory pathology more rapidly and, by the 3rd day of treatment led to complete remission of the symptomatology. "
01/01/2016 - "The members of this international consensus group concluded that nimesulide, when used appropriately, remains a particularly valuable and safe option for the treatment of several conditions characterized by the presence of acute inflammatory pain because of the rapid onset of the analgesic action, and the positive evidence-based benefit/risk profile."
01/01/2009 - "The evaluation of the efficacy of arthrofoon showed a statistically significant positive change in pain (VAS), which corresponded to that in the indices of the pain syndrome during nimesulide administration. "
01/01/1993 - "A significantly greater reduction in pain, functional impairment and swelling was observed with nimesulide compared with placebo; moreover, the time to improvement was significantly shorter with the active treatment. "
07/01/2006 - "After 14 days of treatment, both the plasma and synovial fluid concentrations of M1 were significantly higher than those measured on day 1. These data may help to explain the rapid onset of the analgesic effect of nimesulide demonstrated in several clinical conditions, including painful osteoarthritis."
01/01/1991 - "A multicentric trial was carried out to assess the therapeutic efficacy and tolerability of nimesulide in the treatment of patients with osteoarthritis. "
08/01/2001 - "Here is a report which shows the superiority of nimesulide complexed with betacyclodextrin vs ninesulide tablet in osteoarthritis in a long term study."
08/01/2001 - "Efficacy and safety of nimesulide as well as favourable tolerability have been tested in osteoarthritis in short term study and post-marketing survey. "
01/01/1994 - "A parallel group study for one month of 392 patients was undertaken to define the optimal dose of nimesulide for the treatment of painful osteoarthritis (OA). "
01/01/1993 - "These results confirm the efficacy of nimesulide in the treatment of respiratory inflammation and provide preliminary evidence of its value in children."
01/01/1993 - "Controlled clinical studies of nimesulide in the treatment of urogenital inflammation."
01/01/1984 - "In a double-blind, parallel four-day trial with 51 patients, the anti-inflammatory, antiexudative, and antipyretic effects of nimesulide were compared with placebo in patients with acute inflammation of the upper respiratory tract. "
01/01/1984 - "A double-blind parallel 20-day trial was carried out in 40 patients with acute infectious inflammation of the urogenital tract to compare the effectiveness of antibiotic treatments alone or with concomitant use of a new non-steroidal antiinflammatory drug, 4-nitro-2-phenoxymethane sulfonanilide (nimesulide) 200 mg/d. "
01/01/2015 - "In the AA assay, the best activity was observed for 12 at 3.2 µmol/mouse, with 56.8% reduction of inflammation, in the same range as nimesulide (48.9%). "
10/01/2006 - "nimesulide and 30 Gy radiation (3 Gy/fraction, 10 daily fractions) had significant reduction in tumor size in comparison to the 30 Gy radiation control group (p<0.05). "
10/01/2006 - "In this study we used the COX-2 inhibitor nimesulide to improve the efficacy of RT when measured by tumor regrowth assays in vivo and clonegenic survival in vitro. "
08/01/2011 - "Collectively, results from this study provide data to support that nimesulide analog JCC76 may be a new drug candidate to treat AI-resistant breast cancers. "
06/01/2015 - "In vivo, nimesulide inhibited the growth of Eca-109 tumors and the expression of p-JAK2 and p-STAT3. "
05/01/2015 - "CSUOH0901, a novel anticancer derivative of nimesulide, exhibits very promising anticancer activities in various cancer cell lines. "
|5.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/1983 - "A double-blind, placebo-controlled trial was carried out in 45 hospitalized adult patients requiring antibiotic therapy for acute or chronic respiratory tract infection to compare the effectiveness of antibiotic treatment alone or with the concomitant use of nimesulide, a new non-steroidal anti-inflammatory agent. "
01/01/1993 - "The pharmacokinetic profile and efficacy of nimesulide were assessed in 2 separate studies that recruited children with hypoglycaemia or upper respiratory tract infection and fever, respectively. "
01/01/1991 - "A double-blind, multi-centre study was carried out in 42 hospitalized children, aged 6 months to 8 years, suffering from acute respiratory tract infections with fever, to investigate the antipyretic activity of nimesulide. "
01/01/1993 - "Antipyretic and anti-inflammatory efficacy of nimesulide vs paracetamol in the symptomatic treatment of acute respiratory infections in children."
01/01/1993 - "The efficacy and safety of nimesulide suspension were evaluated in comparison with mefenamic acid in a double-blind multicentre study that recruited 100 children with acute respiratory tract infections. "
|3.||Diclofenac (SR 38)
|4.||Cyclooxygenase 2 (Cyclooxygenase-2)
|6.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
|8.||Aspirin (Acetylsalicylic Acid)
|1.||Cardiopulmonary Resuscitation (CPR)
|2.||Day Care (Partial Hospitalization)
|3.||Oral Surgery (Maxillofacial Surgery)